Watchlist Price Alert

Navidea Biopharmaceutical... (NAVB)

OTC: NAVB · Real-Time Price · USD

0.00

-0.00 (-100.00%)

At close: Apr 04, 2025, 10:19 AM

Navidea Biopharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-15.18M	-11.73M	-10.72M	-10.95M	-16.11M	74.95M	-14.31M
Depreciation & Amortization	95.82K	76.95K	70.39K	144.51K	150.38K	254.59K	501.37K
Stock-Based Compensation	301.35K	471.26K	230.52K	232.06K	306.7K	394.21K	277.54K
Other Working Capital	4.78M	13.61K	13.61K	435.07K	-15.04K	-1.9B	-1.87B
Other Non-Cash Items	675.47K	284.66K	401.74K	34.39K	806.27K	4.04M	4.7M
Deferred Income Tax	n/a	-267.27K	5.65K	60.1K	5.29M	4.64M	-718.76K
Change in Working Capital	5.12M	947.17K	1.84M	1.12M	13.83M	-25.19M	13.11M
Operating Cash Flow	-8.99M	-10.22M	-8.17M	-9.35M	4.28M	59.08M	3.56M
Capital Expenditures	-390.35K	-329.42K	-413.87K	-56.7K	-46.19K	-33.69K	-1.85K
Cash Acquisitions	n/a	n/a	1.04K	27.13K	46.19K	39.22M	45K
Purchase of Investments	n/a	n/a	n/a	n/a	-600K	-2.2M	-110K
Sales Maturities Of Investments	n/a	n/a	n/a	800K	1.6M	400K	27.62K
Other Investing Acitivies	-327.26K	-304.21K	1.04K	27.13K	-46.19K	-39.22M	-65K
Investing Cash Flow	-390.35K	-329.42K	-412.83K	770.42K	953.81K	-1.83M	-39.22K
Debt Repayment	1.98M	-491.77K	-2.55K	-359.06K	-395.57K	-59.75M	-233.61K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-1.01M	-87.32K	-205.05K	-572.27K	-7.15M	-1.31M	-8.92M
Financial Cash Flow	7.14M	12.11M	10.21M	6.16M	-4.55M	-55.99M	-9.14M
Net Cash Flow	-2.24M	1.56M	1.62M	-2.43M	680.88K	1.26M	-5.63M
Free Cash Flow	-9.38M	-10.55M	-8.59M	-9.41M	4.23M	59.05M	3.55M